Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025:43:257-279.
doi: 10.1007/978-3-031-87919-7_10.

Neuroglial Pathophysiology of Leukodystrophies

Affiliations
Review

Neuroglial Pathophysiology of Leukodystrophies

Alexei Verkhratsky et al. Adv Neurobiol. 2025.

Abstract

Leukodystrophies are a diverse group of inherited diseases characterised by white matter degenerative pathology. Leukodystrophies have a highly heterogeneous genetic background linked mainly to mutations in oligodendrocyte and astrocyte genes and, to lesser extent, microglia. The most prevalent leukodystrophies are caused by mutations in oligodendrocyte genes that encode the essential myelin proteins PLP1 and GalC in Pelizaeus-Merzbacher disease and Krabbe disease, respectively. Astrocyte leukodystrophies are led by Alexander disease, caused by mutations in the astrocyte gene GFAP. Vanishing white matter disease, the most prevalent inherited white matter pathology in children, is associated with astrocyte atrophy and cystic degeneration of the cerebral white matter. The pathogenic mechanisms in leukodystrophies depend on the genetic mutations and hence are extremely varied, but the diseases have in common white matter atrophy caused by the loss of oligodendrocytes and myelin, with or without marked reactive astrogliosis and microglia activation. The development of a range of animal models with the disruption of specific genes causing leukodystrophies and the use of pluripotent stem cells from people with different forms of leukodystrophy is advancing the understanding of the functional and cellular pathophysiology of these rare diseases.

Keywords: Aicardi Goutières syndrome; Alexander disease; Astroglial leukodystrophies; Canavan disease; Krabbe disease; Merzbacher disease; Microglial leukodystrophies; Nasu-Hakola disease; Oligodendroglial leukodystrophies; Pelizaeus; Vanishing white matter disease.

PubMed Disclaimer

Similar articles

References

    1. Aicardi, J. (2002). Aicardi-Goutieres syndrome: special type early-onset encephalopathy. Eur J Paediatr Neurol, 6(Suppl A), A1–A7; discussion A23-25, A77-86. - PubMed - DOI
    1. Aicardi, J., & Goutieres, F. (1984). A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Annals of Neurology, 15, 49–54. - PubMed - DOI
    1. Akwa, Y., Hassett, D. E., Eloranta, M. L., Sandberg, K., Masliah, E., Powell, H., Whitton, J. L., Bloom, F. E., & Campbell, I. L. (1998). Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. Journal of Immunology, 161, 5016–5026. - DOI
    1. Alexander, W. S. (1949). Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain, 72, 373–381, 373 pl. - PubMed - DOI
    1. Alonso-Gardon, M., Elorza-Vidal, X., Castellanos, A., La Sala, G., Armand-Ugon, M., Gilbert, A., Di Pietro, C., Pla-Casillanis, A., Ciruela, F., Gasull, X., et al. (2021). Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins. Human Molecular Genetics, 30, 1649–1665. - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources